AMLX - Amylyx Pharmaceuticals Inc Earnings

Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Peers: BIIB VRTX BMRN ALNY SRPT NBIX ACAD SAGE RARE CYTK

| Held by: VTI IWM VXF IBB IWO XPH SCHA VTWO DFMC IWC

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.55	Insider Own	16.51%	Shs Outstand	109.88M	Perf Week	-7.25%
Market Cap	1.78B	Forward P/E	-	EPS next Y	-1.23	Insider Trans	-2.22%	Shs Float	92.29M	Perf Month	15.58%
Enterprise Value	1.46B	PEG	-	EPS next Q	-0.34	Inst Own	95.84%	Short Float	16.07%	Perf Quarter	8.18%
Income	-144.74M	P/S	-	EPS this Y	10.80%	Inst Trans	1.48%	Short Ratio	14.32	Perf Half Y	12.19%
Sales	0.00M	P/B	5.78	EPS next Y	9.94%	ROA	-54.85%	Short Interest	14.83M	Perf YTD	32.99%
Book/sh	2.78	P/C	5.60	EPS next 5Y	29.74%	ROE	-61.59%	52W High	18.60 -13.65%	Perf Year	214.38%
Cash/sh	2.87	P/FCF	-	EPS past 3/5Y	19.94% -15.37%	ROIC	-46.70%	52W Low	4.20 282.50%	Perf 3Y	-43.43%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	5.82% 5.65%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	64.98%	Oper. Margin	-	ATR (14)	0.87	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	14.27	Sales Y/Y TTM	-100.00%	Profit Margin	-	RSI (14)	49.01	Recom	1.25
Dividend Gr. 3/5Y	- -	Current Ratio	14.27	EPS Q/Q	45.12%	SMA20	-4.41%	Beta	-0.14	Target Price	23.30
Payout	-	Debt/Eq	0.02	Sales Q/Q	100.00%	SMA50	5.42%	Rel Volume	0.63	Prev Close	15.60
Employees	136	LT Debt/Eq	0.02	Earnings	Mar 03 BMO	SMA200	23.18%	Avg Volume	1.04M	Price	16.07
IPO	Jan 07, 2022	Option/Short	Yes / Yes	EPS/Sales Surpr.	14.70% 100.00%	Trades		Volume	528,614	Change	2.98%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)